Analysis of Recent Papers in Hypertension Nighttime Administration of At Least One Antihypertensive Medication is Associated With Better Blood Pressure Control and Cardiovascular Outcomes in Patients With Type 2 Diabetes or Chronic Kidney Disease

被引：6
|
作者：
Basile, Jan N. [2 ]
Bloch, Michael J. [1 ]
机构：
[1] Univ Nevada, Sch Med, Dept Internal Med, Reno, NV 89557 USA
[2] Med Univ S Carolina, Ralph H Johnson VA Med Ctr, Div Gen Internal Med Geriatr, Seinsheimer Cardiovasc Hlth Program, Charleston, SC 29425 USA
来源：
JOURNAL OF CLINICAL HYPERTENSION | 2013年 / 15卷 / 01期
关键词：
RISK;
D O I：
10.1111/jch.12028
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：2 / 4
页数：3
相关论文
共 50 条
  • [41] The influence of long-term administration of SGLT2 inhibitors on blood pressure at the office and at home in patients with type 2 diabetes mellitus and chronic kidney disease
    Furuki, Takayuki
    Kobayashi, Kazuo
    Toyoda, Masao
    Hatori, Nobuo
    Sakai, Hiroyuki
    Sato, Kazuyoshi
    Miyakawa, Masaaki
    Tamura, Kouichi
    Kanamori, Akira
    JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (12): : 2306 - 2314
  • [42] Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes
    Mehler, PS
    Coll, JR
    Estacio, R
    Esler, A
    Schrier, RW
    Hiatt, WR
    CIRCULATION, 2002, 106 (19) : 434 - 434
  • [43] Insulin degludec allows for better glycaemic control with a lower risk of hypoglycaemia in patients with chronic kidney disease and type 2 diabetes
    Garcia de Lucas, Maria Dolores
    Aviles Bueno, Beatriz
    Rivas Ruiz, Francisco
    Olalla Sierra, Julian
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162
  • [44] Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes
    Mehler, PS
    Coll, JR
    Estacio, R
    Esler, A
    Schrier, RW
    Hiatt, WR
    CIRCULATION, 2003, 107 (05) : 753 - 756
  • [45] The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
    Lee, Dong-Hwa
    DIABETES & METABOLISM JOURNAL, 2023, 47 (04) : 484 - 486
  • [46] Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"
    Koh, Kwang Kon
    CIRCULATION, 2018, 138 (08) : 846 - 847
  • [47] ASSOCIATION BETWEEN DIABETES MEDICATION USE AND CARDIOVASCULAR EVENTS AMONG TYPE 2 DIABETES PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: A NATIONWIDE COHORT STUDY.
    Chang, H. C.
    Cheng, H. M.
    Chang, P. Y.
    Chiang, C. E.
    Tsai, Y. W.
    VALUE IN HEALTH, 2019, 22 : S407 - S407
  • [48] Intensive Blood Pressure Control, APOL1 Genotype, and Kidney Outcomes in Individuals With Type 2 Diabetes: A Post Hoc Analysis of the Action to Control Cardiovascular Risk in Diabetes-Blood Pressure (ACCORD-BP) Trial
    Dinh, Alex
    Copeland, Timothy
    Freedman, Barry I.
    McCulloch, Charles E.
    Ku, Elaine
    KIDNEY MEDICINE, 2021, 3 (05) : 874 - 876
  • [49] The ankle brachial index exhibits better association with cardiovascular outcomes than interarm systolic blood pressure difference in patients with type 2 diabetes
    Lin, Liang-Yu
    Hwu, Chii-Min
    Chu, Chia-Huei
    Won, Justin G. S.
    Chen, Harn-Shen
    Chang, Li-Hsin
    MEDICINE, 2019, 98 (19)
  • [50] Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease
    Lo, Clement
    Zimbudzi, Edward
    Teede, Helena J.
    Kerr, Peter G.
    Ranasinha, Sanjeeva
    Cass, Alan
    Fulcher, Gregory
    Gallagher, Martin
    Polkinghorne, Kevan R.
    Russell, Grant
    Usherwood, Tim
    Walker, Rowan
    Zoungas, Sophia
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (01) : 63 - 68
12345